abstract |
The present invention discloses dihydroindolinone compounds capable of modulating the activity of protein tyrosine kinases, methods for their preparation, and pharmaceutical compositions comprising the same. Also disclosed are the use of the compounds and pharmaceutical compositions thereof in the treatment and / or prevention of protein tyrosine kinase related diseases in living organisms, in particular in the treatment and / or prevention of tumors and fibroblast proliferation related diseases. |